Finerman said she would stick with low-tech medical device companies that sell things that hospitals need. She liked companies like CR Bard (BCR) and Becton, Dickinson (BDX) that are trading a lot lower than their average multiple over the past five years. "They're winners regardless of the outcome," she said.

Jon Najarian says when the market rallies you want to buy underperformers. So which underperformers is he looking at buying into year’s end? Here’s the short list: UnitedHealth (UNH): up 9% in 2009 Becton, Dickinson (BDX): up only 9% year to date, Lowe’s (LOW): up only 2% year to date.

3

From a recent Mad Money show:"I think this is one of the few medical equipment stocks that benefit from raw costs coming down. This is a company I really like."

From a recent Mad Money show:"I think this is one of the few medical equipment stocks that benefit from raw costs coming down. This is a company I really like."

15.8%

Pharmaceutical Co with diversity and good growth

But for those who think that the decline in commodities is signaling total collapse of the economies, then these will work. Schering-Plough (SGP)? I don't know ... I like Gilead (GILD), which is on fire. Abbott (ABT) had a great quarter. Bard (BCR) and Becton (BDX)? The latter, thought of as a resin play, seems particularly good for the moment.

You can do one of two things: You can attempt to have a longer-term view on the stocks that are doubling and halving, or you can steer clear of all of the nonsense and find the General Mills (GIS) and the C.R. Bards (BCR), the Celgenes (CELG) and the Becton Dickinsons (BDX).

Cramer recommended Becton Dickinson (BDX) as another of his favorite healthcare names. The company manufactures syringes, needles and other surgical supplies and also has a diagnostic division.

Poor fundamentals. It's industry is out of favor wth institutional money, but it is showing a lot of individual interest, due to hyping in the media.